Proteomics

Dataset Information

0

Identification of carcinogenesis and tumor progression processes in pancreatic ductal adenocarcinoma using high-throughput proteomics


ABSTRACT: Pancreatic adenocarcinoma (PDAC) is an aggressive disease with an overall 5 year-survival rate of just 5%. A better understanding of both the carcinogenesis processes and the mechanisms of progression of PDAC disease is mandatory. For this, proteomics data from FFPE samples of 173 primary tumor, normal tissue, preneoplastic lesions (PanIN), or lymph node metastases were analyzed from a Systems Biology perspective. Protein expression data was analyzed using probabilistic graphical models, allowing functional characterization. Functional node activities were calculated as the mean of expression of those proteins related to the main function of each node. Comparisons between groups were done using linear mixed models.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Jamie Feliu  

PROVIDER: MSV000096431 | MassIVE | Fri Nov 15 12:55:00 GMT 2024

SECONDARY ACCESSION(S): PXD032076

REPOSITORIES: MassIVE

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1
altmetric image

Publications


Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with an overall 5-year survival rate of just 5%. A better understanding of the carcinogenesis processes and the mechanisms of the progression of PDAC is mandatory. Fifty-two PDAC patients treated with surgery and adjuvant therapy, with available primary tumors, normal tissue, preneoplastic lesions (PanIN), and/or lymph node metastases, were selected for the study. Proteins were extracted from small punches and analyzed by LC-MS/MS  ...[more]

Similar Datasets

2022-06-21 | PXD032076 | Pride
2013-03-05 | E-GEOD-44408 | biostudies-arrayexpress
2013-03-05 | GSE44408 | GEO
2014-11-24 | E-GEOD-38167 | biostudies-arrayexpress
2021-07-16 | PXD024108 | Pride
2021-08-05 | PXD024852 | Pride
2019-08-29 | PXD013931 | Pride
2016-06-16 | MSV000079830 | MassIVE
2016-01-25 | PXD000815 | Pride
2014-11-24 | GSE38167 | GEO